European Marketing Clearance (CE)

Implanet’s new JAZZ™ Standalone implant receives European marketing clearance (CE)

May 03, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company…